BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20832660)

  • 1. The promise and reality of pharmacogenetics in psychiatry.
    Zandi PP; Judy JT
    Clin Lab Med; 2010 Dec; 30(4):931-74. PubMed ID: 20832660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise and reality of pharmacogenetics in psychiatry.
    Zandi PP; Judy JT
    Psychiatr Clin North Am; 2010 Mar; 33(1):181-224. PubMed ID: 20159346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics, race, and psychiatry: prospects and challenges.
    Jones DS; Perlis RH
    Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in Psychiatry.
    Corponi F; Fabbri C; Serretti A
    Adv Pharmacol; 2018; 83():297-331. PubMed ID: 29801579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric pharmacogenomics in pediatric psychopharmacology.
    Wall CA; Croarkin PE; Swintak C; Koplin BA
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):773-88. PubMed ID: 23040901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.
    Preskorn SH
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 8. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
    DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics. Promise and potential in child and adolescent psychiatry.
    Anderson GM; Cook EH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):23-42, viii. PubMed ID: 10674189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of pharmacogenetics in clinical psychiatry?
    Lombard J; Doraiswamy PM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):1-4. PubMed ID: 23189950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacology in adolescent medicine.
    Scharf MA; Williams TP
    Adolesc Med Clin; 2006 Feb; 17(1):165-81. PubMed ID: 16473299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Personalized medicine in psychiatry -- an old concept from a new aspect].
    Molnar JM
    Neuropsychopharmacol Hung; 2012 Mar; 14(1):2-3. PubMed ID: 22427465
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
    Voirol P; Eap CB; Baumann P
    Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
    [No Abstract]   [Full Text] [Related]  

  • 16. Where are we today with personalized medicine?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of European regulatory policies on psychotropic drug prescribing patterns.
    Garattini S; Bertele' V
    Int Rev Psychiatry; 2005 Jun; 17(3):199-204. PubMed ID: 16194791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic considerations in the treatment of psychiatric disorders.
    Lohoff FW; Ferraro TN
    Expert Opin Pharmacother; 2010 Feb; 11(3):423-39. PubMed ID: 20102306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.